The findings could lead to more tailored treatments for cardiovascular disease. Scientists at the Institutes of Health (NIH) ...

Scientists have made a groundbreaking discovery that could pave the way for new drugs to lower “bad” cholesterol, also known ...

Pharmacy benefits manager CVS Health has warned that the new PCSK9 inhibitor class of cholesterol-lowering drugs poses an unprecedented challenge to the US healthcare system. In a blog post ...

The quest has led to increasingly powerful medicines that plunge LDL to new lows, leading some ... disease who are prescribed cholesterol-lowering drugs, including high intensity therapies ...

Malaria, caused by a parasite transmitted to humans through an infected mosquito's bite, is a leading cause of illness and ...

The researchers hope the breakthrough will help scientists cure a genetic disorder that increases the likelihood of dying from coronary artery disease at a young age.

Structures of ApoB100 show LDL receptor contact points ...

In fact, according to a 2016 analysis in the New England Journal of Medicine ... in combination with certain other drugs, including: The cholesterol-lowering drug ezetimibe (Zetia) has been ...

New Precision Medicine Approach Helps Detect ... 14, 2024 — More than a quarter of Australians over the age of 50 take cholesterol-lowering drugs to prevent heart disease and strokes, but ...

"This breakthrough is a big step forward in developing new malaria treatments," Yu said. "By focusing on PfNCR1, scientists could develop drugs that the parasite finds difficult to develop resistance ...

The new recommendations might serve as a ... may be a lifetime drug. Medications to lower cholesterol were the most-often-prescribed drug in the U.S. in 2009. The FDA approved them to be used ...